139102-34-4, name is Methyl 4-bromo-2-methoxybenzoate, belongs to esters-buliding-blocks compound, is considered to be a conventional heterocyclic compound, which is widely used in drug synthesis. The chemical synthesis route is as follows. Application In Synthesis of Methyl 4-bromo-2-methoxybenzoate
[1003] (l,l’-Bis(ctiphenylphosphmo)ferroc?^ dichloromethane adduct (1.50 g) was added to a mixture of methyl 4-bromo-2-methoxybenzoate (4.50 g), potassium vmyltrifluoroborate (4.92 g), triethylamine (5.12 mL) and ethanol (30 mL), and the resultant was stirred overnight at 100C in an argon atmosphere. Water was added to the reaction mixture, extraction thereof was performed using ethyl acetate, the organic layer was dried over anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure. The obtained residue was purified by a silica gel column chromatography (hexane/ethyl acetate), thereby obtaining the title compound (3.53 g). 1H NMR (300 MHz, CDC13) delta 3.88 (3H, s), 3.93 (3H, s), 538 (1H, d, J = 10.9 Hz), 5.84 (1H, d, J = 17.6 Hz), 6.71 (1H, dd, J = 17.6, 10.9 Hz), 6.98 (1H, s), 7.03 (1H, dd, J = 8.0, 1.4 Hz), 7.78 (l d, J = 8.0 Hz).
The synthetic route of 139102-34-4 has been constantly updated, and we look forward to future research findings.
Reference:
Patent; TAKEDA PHARMACEUTICAL COMPANY LIMITED; KASAI, Shizuo; OGINO, Masaki; MIZOJIRI, Ryo; YAMASAKI, Takeshi; HIROSE, Hideki; TAKAKURA, Nobuyuki; YAMASHITA, Tohru; MORIMOTO, Sachie; NAKAHATA, Takashi; KINA, Asato; WO2014/142363; (2014); A1;,
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics